TY - JOUR T1 - RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma JO - Actas Dermo-Sifiliográficas T2 - AU - Morgado-Carrasco,D. AU - Bosch-Amate,X. AU - Fustà-Novell,X. AU - Giavedoni,P. SN - 15782190 M3 - 10.1016/j.adengl.2018.10.026 DO - 10.1016/j.adengl.2018.10.026 UR - https://actasdermo.org/en-rf-cemiplimab-first-drug-approved-for-articulo-S1578219020300123 ER -